2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 多本ABS四星！优质经管国际期刊列表 | 热 全流程投稿协助套餐服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | MOLECULAR THERAPY MOL THER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.8
63人评分
我要评分
声誉 9.5 影响力 8.2 速度 9.0 | |||||||||||||||||||||||||||||||||
| 期刊ISSN | 1525-0016 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||||||
| E-ISSN | 1525-0024 | |||||||||||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：11.24 | |||||||||||||||||||||||||||||||||
| 2025-2026自引率 | 3.5%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 12.698数据由网友[crystaltraveler53]收集提供 | |||||||||||||||||||||||||||||||||
| h-index | 158 | |||||||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||||
| 期刊官方网站 | https://www.cell.com/molecular-therapy-family/molecular-therapy/home | |||||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/molecular-therapy/default.aspx | |||||||||||||||||||||||||||||||||
| 作者指南网址 | https://www.cell.com/molecular-therapy-family/molecular-therapy/authors | |||||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Anti-CD19-engineered exosomes enable cell-targeted anti-BAFF mRNA delivery alleviate lupus progression Author: Zeng, Linda; Shu, Jingxian; Zhong, Shuping; Dong, Xin; Wu, Yongjian; Huang, Xi Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3417-3435. DOI: 10.1016/j.ymthe.2026.01.037 Lactate-induced miR-7-5p/TRIM33 reprograms metabolic flux to suppress tumor growth and viral reactivation Author: Xu, Yifei; Min, Xuehua; Zhang, Zihan; Zhang, Yulin; Chen, Xiaoting; Wang, Xinyu; Zhu, Caixia; Robertson, Erle; Zhang, Qunling; Tong, Yin; Zhang, Liming; Wang, Yuyan; Cai, Qiliang Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3655-3673. DOI: 10.1016/j.ymthe.2026.02.034 Myeloid-lineage CAR knockin mice enable allogeneic immunotherapy for liver and lung fibrosis Author: Wang, Min; Zhang, Yaoyang; Zhu, Qinyao; Guan, Lili; Xun, Yue; Liu, Yifan; Liu, Yu; Hao, Yuxin; Liu, Shuai; Li, Huan; Shan, Xiaojiao; Li, Xuelong; Fang, Xiaobin; Ju, Yue; Liu, Xiyang; Xia, Shuyue; Yin, Xiushan; Zhang, Luo Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3373-3387. DOI: 10.1016/j.ymthe.2026.01.027 acute liver failure by activating SETD7 and enhancing NLRP3 methylation Author: Nie, Zhentian; Liu, Xiaohan; Zhang, Hongli; Chen, Zhengyang; Sun, Xiaoyan; Li, Yuting; Kong, Yawei; Shu, Hongyan; Chen, Wei Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3599-3615. DOI: 10.1016/j.ymthe.2026.02.016 | |||||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足MOLECULAR THERAPY的语言要求，还能让MOLECULAR THERAPY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被MOLECULAR THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes (Hybrid，可自选是否OA) | |||||||||||||||||||||||||||||||||
| 通讯方式 | CELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||||||||||||||
| 出版商 | Cell Press | |||||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-生物工程与应用微生物 | |||||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||||
| 出版年份 | 2000 | |||||||||||||||||||||||||||||||||
| 年文章数 | 369点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 35.37% | |||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 79.40% | |||||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D | |||||||||||||||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Time to first decision: 8 days; 网友分享经验： 平均1月 | |||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较难 | |||||||||||||||||||||||||||||||||
| APC文章处理费信息 | 版面费：For ASGCT members: $64 per page up to eight printed pages and $128 per page thereafter, additional OA option fee is $3,600; For non-ASGCT members: $116 per page up to eight printed pages and $180 per page thereafter, OA option fee is $4,500; | |||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在MOLECULAR THERAPY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||
| 编辑信息 | Editor-in-Chief Joseph C. Glorioso III, PhD, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA Front matter editor John Bell, PhD, University of Ottawa, Ottawa, Canada | |||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Anti-CD19-engineered exosomes enable cell-targeted anti-BAFF mRNA delivery alleviate lupus progression Author: Zeng, Linda; Shu, Jingxian; Zhong, Shuping; Dong, Xin; Wu, Yongjian; Huang, Xi Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3417-3435. DOI: 10.1016/j.ymthe.2026.01.037 PubMed DOI |
| 2. | Lactate-induced miR-7-5p/TRIM33 reprograms metabolic flux to suppress tumor growth and viral reactivation Author: Xu, Yifei; Min, Xuehua; Zhang, Zihan; Zhang, Yulin; Chen, Xiaoting; Wang, Xinyu; Zhu, Caixia; Robertson, Erle; Zhang, Qunling; Tong, Yin; Zhang, Liming; Wang, Yuyan; Cai, Qiliang Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3655-3673. DOI: 10.1016/j.ymthe.2026.02.034 PubMed DOI |
| 3. | Myeloid-lineage CAR knockin mice enable allogeneic immunotherapy for liver and lung fibrosis Author: Wang, Min; Zhang, Yaoyang; Zhu, Qinyao; Guan, Lili; Xun, Yue; Liu, Yifan; Liu, Yu; Hao, Yuxin; Liu, Shuai; Li, Huan; Shan, Xiaojiao; Li, Xuelong; Fang, Xiaobin; Ju, Yue; Liu, Xiyang; Xia, Shuyue; Yin, Xiushan; Zhang, Luo Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3373-3387. DOI: 10.1016/j.ymthe.2026.01.027 PubMed DOI |
| 4. | acute liver failure by activating SETD7 and enhancing NLRP3 methylation Author: Nie, Zhentian; Liu, Xiaohan; Zhang, Hongli; Chen, Zhengyang; Sun, Xiaoyan; Li, Yuting; Kong, Yawei; Shu, Hongyan; Chen, Wei Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3599-3615. DOI: 10.1016/j.ymthe.2026.02.016 PubMed DOI |
| 5. | Antigen-encoding circular single-stranded DNA for cancer vaccine Author: Liu, Rui; Ye, Rui; Hu, Guang; Chen, Hao; Niu, Muqing; Wang, Ruoyu; Shuai, Xinjia; Ji, Qing; Li, Zhen; Zhang, Yijing; Xu, Yihua; Xie, Ruiyu; Song, Jie Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3504-3517. DOI: 10.1016/j.ymthe.2026.02.030 PubMed DOI |
| 6. | T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation Author: Chen, Yuqi; Yim, Wai Yen; Li, Chenghao; Wang, Zihao; Hou, Jincheng; Peng, Yongbu; Liu, Fayuan; Liu, Zongtao; Dong, Nianguo; Wang, Yixuan Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3484-3502. DOI: 10.1016/j.ymthe.2026.02.015 PubMed DOI |
| 7. | Prosaposin is a dual-action therapeutic target for vascular stabilization and neuroprotection Author: Bai, Jianhao; Li, Sijie; Wang, Aiting; Wang, Boqian; Wan, Zhongqi; Li, Jiao Jiao; Zhou, Yinghong; Jia, RenBing; Jin, Haiying; Gao, Peng; Ding, Xianting Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3674-3697. DOI: 10.1016/j.ymthe.2026.01.015 PubMed DOI |
| 8. | A universal chemoenzymatic labeling system for profiling cell-cell interactions and potentiating targeted tumor immunotherapy Author: Zhou, Hang; Yang, Li-Ting; Zhang, Xin; Li, Shun; Zhu, Jian-Min; Chen, Kai-Ming; Duan, Cai-Wen Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3472-3483. DOI: 10.1016/j.ymthe.2026.05.005 PubMed DOI |
| 9. | Low-dose AAV9-SMN1 with CNS-selective expression delivers efficacy and favorable safety in spinal muscular atrophy Author: Yu, Yongguo; Qin, Xiji; Jing, Mengxia; Huang, Carol; Zhou, Xin; Fan, Yanjie; Rao, Jia; Xia, Hongping; Dai, Weiqian; Luo, Xiaomei; Liu, Hui; Cao, Shihua; Shen, Yanjun; Qiu, Yao; Zhang, Qianru; Li, Shuqi; Su, Ling; Wang, Yi; Hou, Jay; Sun, Kun Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3287-3299. DOI: 10.1016/j.ymthe.2026.02.050 PubMed DOI |
| 10. | Exogenous photoreceptor-specific N-glycosylated PROM1 rescues retinal degeneration in patient and mouse models Author: Xu, Ping; Guo, Fuying; Wang, Yuan; Chen, Guifu; Song, Xiaojing; Luo, Bella Y.; Zheng, Dandan; Gao, Guanjie; Yin, Wenjing; Zhang, Suai; Lahn, Bruce T.; Zhong, Xiufeng Journal: MOLECULAR THERAPY. 2026; Vol. 34, Issue 6, pp. 3270-3286. DOI: 10.1016/j.ymthe.2026.02.040 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共205条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
